Interestingly, the fusion protein 33A provided higher tumour uptake values compared to other conjugates at as early as 6 h p.i., likely due to elevated fraction of freely circulating 33A (i.e., not bound to albumin) that also leads to more rapid blood clearance. The gene discussed is ALB; the disease is neoplasm.